{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:55:13Z","timestamp":1791903313247,"version":"4.3.4"},"reference-count":33,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is characterized by recurrent chromosomal abnormalities that form the basis of the European LeukemiaNet risk classification and serve as essential determinants of prognosis and therapeutic decision-making. Conventional metaphase karyotyping remains the diagnostic gold standard for detecting these abnormalities; however, its utility is limited by longer turnaround times, often delaying critical clinical management. Here, we present a long-read, low-coverage whole-genome sequencing (lcWGS) approach using Oxford Nanopore Technology as a rapid and scalable alternative for cytogenetic profiling. A total of 100 diagnostic AML samples were analyzed, comprising 50 retrospectively selected patients with known adverse-risk cytogenetics and 50 prospectively enrolled patients with clinically defined de novo AML. LcWGS demonstrated robust analytical performance, identifying chromosomal aberrations with 93% sensitivity, specificity, and overall accuracy, respectively. Complex karyotypes were reliably detected, with an area under the curve of 0.971. Reproducibility was validated through replicate sequencing at 2 independent laboratories (R = 0.99). LcWGS-derived estimates of clone size showed moderate correlation with conventional cytogenetic assessments (R = 0.54). Patients with complex karyotypes identified by lcWGS exhibited significantly shorter overall and relapse-free survival, closely mirroring outcomes defined by conventional karyotyping and underscoring the value of lcWGS for risk stratification. The median turnaround time from sample receipt to bioinformatics interpretation was \u223c34 hours, enabling delivery of actionable karyotype results within 72 hours. These findings establish lcWGS as a rapid, reproducible, and accurate platform for detecting clinically relevant chromosomal abnormalities, addressing a critical need for timely risk stratification and treatment initiation in AML.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019960","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:54:19Z","timestamp":1782424459000},"page":"6774-6784","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Rapid and reproducible karyotyping with long-read sequencing in patients with AML"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-9044","authenticated-orcid":false,"given":"Michael","family":"Heuser","sequence":"first","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"},{"name":"2Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-2900","authenticated-orcid":false,"given":"Anna","family":"Dolnik","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5378-4523","authenticated-orcid":false,"given":"Isabell","family":"Arnhardt","sequence":"additional","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courteney K.","family":"Lai","sequence":"additional","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0741-1166","authenticated-orcid":false,"given":"Ekaterina","family":"Jahn","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Salim","sequence":"additional","affiliation":[{"name":"5Department of Human Genetics, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"G\u00f6hring","sequence":"additional","affiliation":[{"name":"6VZ Amedes Genetics f\u00fcr interdisziplin\u00e4re Labordiagnostik GmbH, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne Lisa","family":"Behrens","sequence":"additional","affiliation":[{"name":"5Department of Human Genetics, Hannover Medical School, Hannover, Germany"},{"name":"7Institute of Medical Genetics, Carl von Ossietzky University Oldenburg, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"L\u00fchmann","sequence":"additional","affiliation":[{"name":"5Department of Human Genetics, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Steinemann","sequence":"additional","affiliation":[{"name":"5Department of Human Genetics, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wichmann","sequence":"additional","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Florian","family":"Schrezenmeier","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-5641","authenticated-orcid":false,"given":"Yasmine","family":"Alwie","sequence":"additional","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4187-2513","authenticated-orcid":false,"given":"Arnold","family":"Kloos","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9756-4487","authenticated-orcid":false,"given":"Gesa","family":"Baurmann","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Westermann","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"8Labor Berlin - Charit\u00e9 Vivantes Ltd, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-1173","authenticated-orcid":false,"given":"Frederik","family":"Damm","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"9German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2116-5536","authenticated-orcid":false,"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-4304","authenticated-orcid":false,"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas R.","family":"Thol","sequence":"additional","affiliation":[{"name":"1Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4304-5079","authenticated-orcid":false,"given":"Olga","family":"Blau","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"8Labor Berlin - Charit\u00e9 Vivantes Ltd, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2261-9862","authenticated-orcid":false,"given":"Konstanze","family":"D\u00f6hner","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-5510","authenticated-orcid":false,"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"8Labor Berlin - Charit\u00e9 Vivantes Ltd, Berlin, Germany"},{"name":"9German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-1134","authenticated-orcid":false,"given":"Razif","family":"Gabdoulline","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-8735","authenticated-orcid":false,"given":"Jan Eric","family":"Str\u00e4ng","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oncology and Cancer Immunology, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"20","key":"2026101310424937400_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2026101310424937400_bib2","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2352-3026(21)00134-4","article-title":"CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial","volume":"8","author":"Lancet","year":"2021","journal-title":"Lancet Haematol"},{"issue":"26","key":"2026101310424937400_bib3","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","article-title":"CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia","volume":"36","author":"Lancet","year":"2018","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026101310424937400_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2026101310424937400_bib5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2026101310424937400_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"2026101310424937400_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.50","article-title":"Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities","volume":"18","author":"Mikhail","year":"2016","journal-title":"Genet Med"},{"issue":"24","key":"2026101310424937400_bib8","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1182\/bloodadvances.2022008000","article-title":"The need for rapid cytogenetics in the era of unique therapies for acute myeloid leukemia","volume":"6","author":"Vijayanarayanan","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"2026101310424937400_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/bloodadvances.2020002517","article-title":"Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML","volume":"5","author":"Mareschal","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"2026101310424937400_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2018.194258","article-title":"Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing","volume":"104","author":"Mack","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"2026101310424937400_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"2026101310424937400_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gpb.2016.05.004","article-title":"Oxford nanopore MinION sequencing and genome assembly","volume":"14","author":"Lu","year":"2016","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2026101310424937400_bib13","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1016\/j.csbj.2021.07.030","article-title":"Application of long-read sequencing to the detection of structural variants in human cancer genomes","volume":"19","author":"Sakamoto","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"12","key":"2026101310424937400_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00277-017-3150-3","article-title":"Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)","volume":"96","author":"Nagel","year":"2017","journal-title":"Ann Hematol"},{"key":"2026101310424937400_bib15","volume-title":"ISCN 2020: An International System for Human Cytogenomic Nomenclature (2020) Reprint of 'Cytogenetic and Genome Research 2020, Vol. 160, No. 7-8","year":"2020"},{"issue":"16","key":"2026101310424937400_bib16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-02-829911","article-title":"Measurable residual disease (MRD) monitoring by NGS before allogeneic hematopoietic cell transplantation in AML","volume":"132","author":"Thol","year":"2018","journal-title":"Blood"},{"issue":"9","key":"2026101310424937400_bib17","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/bloodadvances.2021004367","article-title":"Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations","volume":"5","author":"Heuser","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"2026101310424937400_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41592-018-0001-7","article-title":"Accurate detection of complex structural variations using single-molecule sequencing","volume":"15","author":"Sedlazeck","year":"2018","journal-title":"Nat Methods"},{"issue":"17","key":"2026101310424937400_bib19","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.3390\/cancers13174388","article-title":"The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia","volume":"13","author":"L\u00fchmann","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"2026101310424937400_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"16","key":"2026101310424937400_bib21","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/bty1055","article-title":"ACE: absolute copy number estimation from low-coverage whole-genome sequencing data","volume":"35","author":"Poell","year":"2019","journal-title":"Bioinformatics"},{"issue":"7","key":"2026101310424937400_bib22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/bioinformatics\/bti146","article-title":"CyDAS: a cytogenetic data analysis system","volume":"21","author":"Hiller","year":"2005","journal-title":"Bioinformatics"},{"issue":"29","key":"2026101310424937400_bib23","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","article-title":"Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype","volume":"26","author":"Breems","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026101310424937400_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12864-021-07686-z","article-title":"Evaluation of tools for identifying large copy number variations from ultra-low-coverage whole-genome sequencing data","volume":"22","author":"Smolander","year":"2021","journal-title":"BMC Genomics"},{"issue":"1","key":"2026101310424937400_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41408-024-01108-5","article-title":"Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia","volume":"14","author":"Kato","year":"2024","journal-title":"Blood Cancer J"},{"issue":"8","key":"2026101310424937400_bib26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/genes15081100","article-title":"Comparative analysis of two NGS-based platforms for product-of-conception karyotyping","volume":"15","author":"Murase","year":"2024","journal-title":"Genes (Basel)"},{"issue":"9","key":"2026101310424937400_bib27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3390\/cancers14092058","article-title":"Optical genome mapping as a diagnostic tool in pediatric acute myeloid leukemia","volume":"14","author":"Suttorp","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"2026101310424937400_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41698-025-01258-0","article-title":"Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AML","volume":"10","author":"Torres-Hern\u00e1ndez","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"2026101310424937400_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12859-016-1174-7","article-title":"CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data","volume":"17","author":"Yu","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2026101310424937400_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13059-025-03599-2","article-title":"Tumor ploidy determination in low-pass whole genome sequencing and allelic copy number visualization using the Constellation Plot","volume":"26","author":"Johnson","year":"2025","journal-title":"Genome Biol"},{"issue":"5","key":"2026101310424937400_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41375-025-02565-y","article-title":"Real-time genomic characterization of pediatric acute leukemia using adaptive sampling","volume":"39","author":"Geyer","year":"2025","journal-title":"Leukemia"},{"issue":"11","key":"2026101310424937400_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.2025031480","article-title":"2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party","volume":"147","author":"Cloos","year":"2025","journal-title":"Blood"},{"issue":"9","key":"2026101310424937400_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ajh.70000","article-title":"Impact of cytogenetic response to therapy on long-term survival in acute myeloid leukemia","volume":"100","author":"Hanna","year":"2025","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6774\/2593921\/blooda_adv-2026-019960-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6774\/2593921\/blooda_adv-2026-019960-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:42:56Z","timestamp":1791902576000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/19\/6774\/569381\/Rapid-and-reproducible-karyotyping-with-long-read"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":33,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019960","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,13]]},"published":{"date-parts":[[2026,10,6]]}}}